These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12176054)

  • 1. Divalent hammerhead ribozyme targeting template region of human telomerase RNA has potent cleavage activity, but less inhibitory activity on telomerase.
    Yokoyama Y; Wan X; Takahashi Y; Shinohara A; Liulin T; Tamaya T
    Arch Biochem Biophys; 2002 Sep; 405(1):32-7. PubMed ID: 12176054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells.
    Yokoyama Y; Takahashi Y; Shinohara A; Lian Z; Wan X; Niwa K; Tamaya T
    Cancer Res; 1998 Dec; 58(23):5406-10. PubMed ID: 9850072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of telomerase activity by hammerhead ribozyme targeting human telomerase RNA induces growth retardation and apoptosis in human breast tumor cells.
    Yeo M; Rha SY; Jeung HC; Hu SX; Yang SH; Kim YS; An SW; Chung HC
    Int J Cancer; 2005 Apr; 114(3):484-9. PubMed ID: 15551309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hammerhead ribozymes to modulate telomerase activity of endometrial carcinoma cells.
    Yokoyama Y; Wan X; Shinohara A; Takahashi Y; Tamaya T
    Hum Cell; 2001 Sep; 14(3):223-31. PubMed ID: 11774741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity.
    Yokoyama Y; Takahashi Y; Shinohara A; Wan X; Takahashi S; Niwa K; Tamaya T
    Biochem Biophys Res Commun; 2000 Jun; 273(1):316-21. PubMed ID: 10873604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-enzymatic in vitro production of circular hammerhead ribozyme targeting the template region of human telomerase RNA.
    Ochi A; Umekage S; Kikuchi Y
    Nucleic Acids Symp Ser (Oxf); 2009; (53):275-6. PubMed ID: 19749367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of telomerase activity by hammerhead ribozymes targeting human telomerase RNA and telomerase reverse transcriptase in pancreatic carcinoma cells.
    Hayashidani Y; Hiyama E; Murakami Y; Sueda T
    Hiroshima J Med Sci; 2005 Mar; 54(1):21-7. PubMed ID: 15847061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells.
    Kanazawa Y; Ohkawa K; Ueda K; Mita E; Takehara T; Sasaki Y; Kasahara A; Hayashi N
    Biochem Biophys Res Commun; 1996 Aug; 225(2):570-6. PubMed ID: 8753802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of telomerase activity by HDV ribozyme in cancers.
    Lu Y; Gu J; Jin D; Gao Y; Yuan M
    J Exp Clin Cancer Res; 2011 Jan; 30(1):1. PubMed ID: 21208462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of a ribozyme targeting human telomerase reverse transcriptase and cloning of it's gene.
    Hao ZM; Luo JY; Cheng J; Wang QY; Yang GX
    World J Gastroenterol; 2003 Jan; 9(1):104-7. PubMed ID: 12508361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of telomerase activity by a hammerhead ribozyme targeting the RNA component of telomerase in human melanoma cells.
    Folini M; Colella G; Villa R; Lualdi S; Daidone MG; Zaffaroni N
    J Invest Dermatol; 2000 Feb; 114(2):259-67. PubMed ID: 10651984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unusual interactions between cleavage products of a cis-cleaving hammerhead ribozyme.
    Castanotto D; Chow WA; Li H; Rossi JJ
    Antisense Nucleic Acid Drug Dev; 1998 Dec; 8(6):499-506. PubMed ID: 9918114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extended target-site specificity for a hammerhead ribozyme.
    Perriman R; Delves A; Gerlach WL
    Gene; 1992 Apr; 113(2):157-63. PubMed ID: 1572538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Target sequence-specific inhibition of HIV-1 replication by ribozymes directed to tat RNA.
    Sun LQ; Wang L; Gerlach WL; Symonds G
    Nucleic Acids Res; 1995 Aug; 23(15):2909-13. PubMed ID: 7544887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of hammerhead ribozymes cleaving mdr-1 mRNA.
    Palfner K; Kneba M; Hiddemann W; Bertram J
    Biol Chem Hoppe Seyler; 1995 May; 376(5):289-95. PubMed ID: 7544982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Application of hammerhead ribozyme targeting telomerase molecule for cancer therapy].
    Yokoyama Y; Takahashi Y; Shinohara A; Tamaya T
    Nihon Rinsho; 1998 May; 56(5):1126-30. PubMed ID: 9613108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selection of a purine nucleotide-specific hammerheadlike ribozyme.
    Vaish NK; Heaton PA; Fedorova O; Eckstein F
    Proc Natl Acad Sci U S A; 1998 Mar; 95(5):2158-62. PubMed ID: 9482855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of structure in a long target RNA on ribozyme cleavage efficiency.
    Campbell TB; McDonald CK; Hagen M
    Nucleic Acids Res; 1997 Dec; 25(24):4985-93. PubMed ID: 9396806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Catalytic properties of hairpin ribozymes derived from Chicory yellow mottle virus and arabis mosaic virus satellite RNAs.
    DeYoung M; Siwkowski AM; Lian Y; Hampel A
    Biochemistry; 1995 Dec; 34(48):15785-91. PubMed ID: 7495810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cleavage of viral RNA and inhibition of viral translation by hepatitis C virus RNA-specific hammerhead ribozyme in vitro.
    Ohkawa K; Yuki N; Kanazawa Y; Ueda K; Mita E; Sasaki Y; Kasahara A; Hayashi N
    J Hepatol; 1997 Jul; 27(1):78-84. PubMed ID: 9252077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.